Skip to main content

and
  1. Article

    Insulin X10 revisited: a super-mitogenic insulin analogue

    The molecular safety of insulin analogues has received a great deal of attention over the last year. In particular, attention has been directed to the mitogenic properties of insulin analogues as compared with...

    B. F. Hansen, P. Kurtzhals, A. B. Jensen, A. Dejgaard, D. Russell-Jones in Diabetologia (2011)

  2. Article

    No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

    Recent epidemiological studies suggest that treatment with insulin glargine (A21Gly,B31Arg,B32Arg human insulin) may promote cancer growth. The present meta-analysis was performed to assess the risk of cancer ...

    A. Dejgaard, H. Lynggaard, J. Råstam, M. Krogsgaard Thomsen in Diabetologia (2009)

  3. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)

  4. No Access

    Article

    Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

    The effect on postprandial blood glucose control of an immediately pre-meal injection of the rapid acting insulin analogue Aspart (IAsp) was compared with that of human insulin Actrapid injected immediately o...

    A.M. Rosenfalck, P. Thorsby, L. Kjems, K. Birkeland, A. Dejgaard in Acta Diabetologica (2000)

  5. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)

  6. Article

    Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients

    The prevalence of micro- and macroalbuminuria was determined in Type 2 (non-insulin-dependent) diabetic patients, less than 76 years of age, attending a diabetic clinic during 1987. All eligible patients (n=557) ...

    M. -A. Gall, P. Rossing, P. Skøtt, P. Damsbo, A. Vaag, K. Bech, A. Dejgaard in Diabetologia (1991)

  7. Article

    Plasma adrenaline kinetics in Type 1 (insulin-dependent) diabetic patients with and without autonomie neuropathy

    Plasma adrenaline kinetics (clearance, extraction across the forearm, initial plasma disappearance rate, mean sojourn time, volume of distribution) were studied in sixteen Type 1 (insulin-dependent) diabetic p...

    A. Dejgaard, J. Hilsted, J. H. Henriksen, N. J. Christensen in Diabetologia (1989)

  8. No Access

    Article

    Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in men with duodenal ulcer

    The effects of treatment for 2 years with the histamine H2-receptor antagonist ranitidine (100 or 200 mg b.d. for 6 weeks followed by 100 or 200 mg daily) on plasma concentrations of pituitary and peripheral horm...

    U. Knigge, B. Thuesen, A. Dejgaard, P. Bennett in European Journal of Clinical Pharmacology (1989)